Clinical Trial Update: Armodafinil in Binge Eating Disorder (BED) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of armodafinil for Binge Eating Disorder has completed. The update notes the study status but does not provide results in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder
• Obesity

Drugs mentioned

• NUVIGIL (armodafinil)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Binge Eating Disorder, Overweight | Phase 3 | Status: COMPLETED